Novartis Will Not Acquire Berna
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis will not extend an acquisition offer to Swiss vaccines company Berna Biotech, the firms announced Jan. 10
You may also be interested in...
Crucell Gains Contract Manufacturing Company With SBL Acquisition
Acquisition, valued at $50.5 mil., is expected to complete on Nov. 23.
Crucell Gains Contract Manufacturing Company With SBL Acquisition
Acquisition, valued at $50.5 mil., is expected to complete on Nov. 23.
Novartis Considers Joining Swiss Vaccines Firm Berna With Chiron
The firm would have to outbid a roughly $450 mil. bid from Dutch biotech company Crucell.